| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |